Status:
COMPLETED
Pretreatment With Unfractionated Heparin for ST Elevation Myocardial Infarction
Lead Sponsor:
University Medical Centre Ljubljana
Conditions:
STEMI - ST Elevation Myocardial Infarction
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Rupture of a coronary artery plaque leads to thrombotic occlusion of the coronary artery and would present as ST segment elevation myocardial infarction. Early treatment with aspirin and early primary...
Detailed Description
Randomization of patients with STEMI at first medical contact in a 1:1 ratio into an intervention group receiving 100 IU of unfractionated heparin (UFH) per kilogram of body weight IV and later additi...
Eligibility Criteria
Inclusion
- Adult patients with STEMI referred for primary PCI
- Duration of symptoms less than 6 hours before presentation
Exclusion
- Pregnancy
- Cardiogenic shock at presentation (hemodynamic instability)
- Cardiac arrest before randomization
- Duration of symptoms for more than 6 hours before presentation
Key Trial Info
Start Date :
March 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 5 2025
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT05247424
Start Date
March 10 2022
End Date
March 5 2025
Last Update
May 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UMC Ljubljana
Ljubljana, Slovenia, 1000